Insulin resistance (IR) is a key feature of type 2 diabetes, characterized by impaired glucose metabolism in tissues such as the liver, adipose tissue, and skeletal muscle. It is associated with hyperglycemia, hyperinsulinemia, hyperlipidemia, and disrupted glucose homeostasis. The molecular mechanisms underlying IR involve multiple pathways, including defects in insulin signaling, inflammation, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and the accumulation of lipids in non-adipose tissues. Key factors contributing to IR include lipotoxicity, increased adiposity, inflammatory signaling, ER stress, adipokines, mitochondrial dysfunction, and elevated free fatty acids (FFAs). Insulin signaling begins with the activation of the insulin receptor (INSR), leading to the phosphorylation of insulin receptor substrates (IRS) and downstream signaling molecules such as PI3K and AKT. These pathways regulate glucose uptake, glycogen synthesis, and lipid metabolism. However, in IR, these pathways are impaired, leading to reduced insulin action. In skeletal muscle, IR is associated with defects in glucose transport and glycogen storage, while in the liver, it is linked to increased gluconeogenesis and reduced glycogen synthesis. In adipose tissue, IR is characterized by impaired lipolysis and lipogenesis. Inflammation plays a significant role in IR, with pro-inflammatory cytokines such as TNF-α and IL-6 contributing to insulin resistance. Adipokines, including leptin and adiponectin, also influence insulin sensitivity. Mitochondrial dysfunction and ER stress further exacerbate IR by impairing energy metabolism and increasing reactive oxygen species (ROS) production. Ectopic lipid accumulation in tissues such as the liver and skeletal muscle is a major contributor to IR, often resulting from metabolic overload and dysregulated lipid metabolism. The development of IR is a complex interplay of multiple factors, including genetic, metabolic, and environmental influences. Understanding these mechanisms is crucial for developing effective therapeutic strategies to combat this multifaceted condition. Current research highlights the importance of targeting these pathways to improve insulin sensitivity and prevent the progression of type 2 diabetes.Insulin resistance (IR) is a key feature of type 2 diabetes, characterized by impaired glucose metabolism in tissues such as the liver, adipose tissue, and skeletal muscle. It is associated with hyperglycemia, hyperinsulinemia, hyperlipidemia, and disrupted glucose homeostasis. The molecular mechanisms underlying IR involve multiple pathways, including defects in insulin signaling, inflammation, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and the accumulation of lipids in non-adipose tissues. Key factors contributing to IR include lipotoxicity, increased adiposity, inflammatory signaling, ER stress, adipokines, mitochondrial dysfunction, and elevated free fatty acids (FFAs). Insulin signaling begins with the activation of the insulin receptor (INSR), leading to the phosphorylation of insulin receptor substrates (IRS) and downstream signaling molecules such as PI3K and AKT. These pathways regulate glucose uptake, glycogen synthesis, and lipid metabolism. However, in IR, these pathways are impaired, leading to reduced insulin action. In skeletal muscle, IR is associated with defects in glucose transport and glycogen storage, while in the liver, it is linked to increased gluconeogenesis and reduced glycogen synthesis. In adipose tissue, IR is characterized by impaired lipolysis and lipogenesis. Inflammation plays a significant role in IR, with pro-inflammatory cytokines such as TNF-α and IL-6 contributing to insulin resistance. Adipokines, including leptin and adiponectin, also influence insulin sensitivity. Mitochondrial dysfunction and ER stress further exacerbate IR by impairing energy metabolism and increasing reactive oxygen species (ROS) production. Ectopic lipid accumulation in tissues such as the liver and skeletal muscle is a major contributor to IR, often resulting from metabolic overload and dysregulated lipid metabolism. The development of IR is a complex interplay of multiple factors, including genetic, metabolic, and environmental influences. Understanding these mechanisms is crucial for developing effective therapeutic strategies to combat this multifaceted condition. Current research highlights the importance of targeting these pathways to improve insulin sensitivity and prevent the progression of type 2 diabetes.